FIELD: medicine; gynaecology.
SUBSTANCE: hysteromyoma patients are examined for menarche age, medical abortions before first labour, inflammatory complications of medical abortions, arterial hypertension during previous pregnancies, anomalies of birth activity, inflammatory postnatal diseases, sexual satisfaction, body weight index, essential hypertension and chronic gastrointestinal disturbances. The prediction measure of clinical hysteromyoma course is calculated by formula and used to predict hysteromyoma course with clinical symptomatology development.
EFFECT: method allows for high-accuracy prediction of hysteromyoma course with clinical symptomatology development considering the anamnesis data.
1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREDICTING FAST GROWTH OF HYSTEROMYOMA | 2007 |
|
RU2350259C1 |
METHOD FOR PREDICTION OF RISK OF RECURRENCE OF SYMPTOMATIC UTERINE MYOMA AFTER SELECTIVE EMBOLIZATION OF UTERINE ARTERIES | 2021 |
|
RU2766809C1 |
METHOD FOR PREDICTING THE DEGREE OF RISK OF PELVIC ORGAN PROLAPSE FORMATION IN WOMEN | 2021 |
|
RU2766168C1 |
METHOD FOR INDIVIDUAL PREDICTION OF INTRANATAL FOETAL DEATH | 2015 |
|
RU2574714C1 |
METHOD FOR PREDICTING RISK OF HYSTEROMYOMA | 2014 |
|
RU2550933C1 |
METHOD FOR PREDICTING THE RISK OF DEVELOPING UNFAVOURABLE MATERNAL OUTCOMES DURING PREGNANCY, CHILDBIRTH AND THE POSTPARTUM PERIOD | 2023 |
|
RU2803129C1 |
METHOD OF ESTIMATING RISK TO PREGNANCY IN PRENATAL PERIOD BY RESULTS OF MASS MONITORING OF PREGNANT WOMEN AT REGIONAL LEVEL | 2012 |
|
RU2497437C1 |
DIAGNOSTIC TECHNIQUE FOR DETERMINING PROBABILITY OF LOCAL INFLAMMATION DEVELOPMENT IN MYOMATOUS NODULE | 2014 |
|
RU2592242C2 |
DEVICE FOR VAGINAL SPHINCTER CONTRACTION STRENGTH TEST | 2014 |
|
RU2545889C1 |
METHOD OF PREDICTION OF PERINATAL FOETAL DEATH | 2015 |
|
RU2605809C1 |
Authors
Dates
2009-05-20—Published
2007-10-11—Filed